University of Maryland School of Medicine researchers engineered a novel protein-based antidote demonstrating promising efficacy in rapidly removing carbon monoxide with fewer adverse effects compared to current agents. Detailed in the Proceedings of the National Academy of Sciences, this breakthrough could revolutionize treatment for carbon monoxide poisoning, which remains a significant cause of morbidity and mortality globally. Early studies highlight improved therapeutic profiles, paving the way for clinical development.